Atlas Trials

A Study of LY3127804 in Participants With COVID-19

Clinical trial NCT04342897 · TERMINATED

Trial details

NCT number
NCT04342897
Sponsor
Eli Lilly and Company
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Pneumonia
Start date
2020-04-20
Primary completion
2020-10-12
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.